Winton Group’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-7,788
| Closed | -$256K | – | 1012 |
|
|
2021
Q3 | $256K | Buy |
7,788
+569
| +8% | +$18.7K | 0.01% | 1157 |
|
|
2021
Q2 | $253K | Sell |
7,219
-898
| -11% | -$31.5K | 0.01% | 1273 |
|
|
2021
Q1 | $293K | Sell |
8,117
-1,535
| -16% | -$55.4K | 0.02% | 1152 |
|
|
2020
Q4 | $280K | Sell |
9,652
-17,752
| -65% | -$515K | 0.02% | 1072 |
|
|
2020
Q3 | $773K | Sell |
27,404
-15,162
| -36% | -$428K | 0.03% | 927 |
|
|
2020
Q2 | $1.38M | Buy |
+42,566
| New | +$1.38M | 0.04% | 827 |
|
|
2019
Q4 | – | Sell |
-13,672
| Closed | -$996K | – | 1533 |
|
|
2019
Q3 | $996K | Buy |
13,672
+5,804
| +74% | +$423K | 0.01% | 829 |
|
|
2019
Q2 | $647K | Buy |
7,868
+3,509
| +81% | +$289K | 0.01% | 570 |
|
|
2019
Q1 | $307K | Buy |
+4,359
| New | +$307K | 0.01% | 795 |
|
|
2018
Q3 | – | Sell |
-4,313
| Closed | -$288K | – | 1010 |
|
|
2018
Q2 | $288K | Sell |
4,313
-1,568
| -27% | -$105K | 0.01% | 844 |
|
|
2018
Q1 | $342K | Buy |
+5,881
| New | +$342K | 0.01% | 925 |
|